Patent · US Active

Macrocyclic nucleoside phosphoramidate derivatives

US8846638B2 · kind B2 · utility

23Cited by

5References

22Claims

0Family size

Assignee

Enanta Pharmaceuticals, Inc. · US

Inventors

Yat Sun Or · Watertown, US
Jun Ma · Jingwei, CN
Guoqiang Wang · Shandong, CN

Key dates

Filing date	May 17, 2013
Grant date	Sep 30, 2014
Priority date	—
Expiry date	May 17, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07H19/23
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides nucleoside phosphoramidate compounds of Formula I,where R1, R2a, R2b, R3, R4, R5a, R5b, R6, R7, R8a, R8b, M and W are as defined herein. The invention further includes pharmaceutical compositions comprising a compound of Formula I, methods of use of these compounds for treating a viral infection, and methods of producing these compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.